Search results for "Infectious"

showing 10 items of 2953 documents

Nonlinear intestinal absorption kinetics of cefuroxime axetil in rats.

1997

Cefuroxime is commercially available for parenteral administration as a sodium salt and for oral administration as cefuroxime axetil, the 1-(acetoxy)ethyl ester of the drug. Cefuroxime axetil is a prodrug of cefuroxime and has little, if any, antibacterial activity until hydrolyzed in vivo to cefuroxime. In this study, the absorption of cefuroxime axetil in the small intestines of anesthetized rats was investigated in situ, by perfusion at four concentrations (11.8, 5, 118 and 200 microM). Oral absorption of cefuroxime axetil can apparently be described as a specialized transport mechanism which obeys Michaelis-Menten kinetics. Parameters characterizing absorption of prodrug in free solutio…

PharmacologyMaleCefuroximeChromatographyChemistryAbsorption (skin)ProdrugPharmacologyIntestinal absorptionBioavailabilityCephalosporinsRatsInfectious DiseasesPharmacokineticsIntestinal AbsorptionOral administrationIntestine SmallmedicineAnimalsPharmacology (medical)Rats WistarCefuroximemedicine.drugAntibacterial agentResearch Article
researchProduct

Adverse cutaneous reactions associated with the newest antiretroviral drugs in patients with human immunodeficiency virus infection.

2008

HIV-infected patients have a higher risk of developing cutaneous reactions than the general population, which has a significant impact on patients' current and future care options. The severity of cutaneous adverse reactions varies greatly, and some may be difficult to manage. HIV-infected patients just at the beginning of antiretroviral treatment can frequently show a wide variety of adverse drug effects such as drug rashes, hyperpigmentation, hair loss, hypersensitivity reactions, injection site reaction, urticarial reaction, erythema multiforme, toxic epidermal necrolysis or Stevens-Johnson syndrome. The early detection and treatment of cutaneous adverse drug reactions, plus identificati…

PharmacologyMicrobiology (medical)Enfuvirtidebusiness.industryAnti-HIV AgentsEtravirineIntegrase inhibitorHIV Infectionsmedicine.diseaseRaltegravirSkin Diseaseschemistry.chemical_compoundInfectious DiseaseschemistryInjection site reactionImmunologymedicineHumansPharmacology (medical)Protease inhibitor (pharmacology)businessTipranavirmedicine.drugMaravirocThe Journal of antimicrobial chemotherapy
researchProduct

Posaconazole concentrations in the central nervous system

2008

more susceptible to the killing activity of caspofungin. This study is the first comparing caspofungin killing activity against the closely related species C. parapsilosis, C. orthopsilosis and C. metapsilosis. Killing curves, regardless of the medium used, showed a decreasing order of susceptibility to caspofungin: C. metapsilosis . C. orthopsilosis . C. parapsilosis. Based on high echinocandin MICs for C. parapsilosis sensu stricto, in the case of isolates identified as C. parapsilosis sensu lato low MICs of echinocandins may be regarded as an indicator that an isolate is in fact C. orthopsilosis or C. metapsilosis; in the case of isolates with low echinocandin MICs, DNA-based identificat…

PharmacologyMicrobiology (medical)PosaconazoleEchinocandinBiologyPharmacologybacterial infections and mycosesBiological fluidMicrobiologychemistry.chemical_compoundInfectious Diseaseschemistryparasitic diseasespolycyclic compoundsTriazole derivativesmedicinePharmacology (medical)CaspofunginEchinocandinsSensu strictoSerum chemistrymedicine.drugJournal of Antimicrobial Chemotherapy
researchProduct

New agents active against Mycobacterium avium complex selected by molecular topology: a virtual screening method

2003

Objectives: In order to select new drugs and to predict their in vitro activity against Mycobacterium avium complex (MAC), new quantitative structure-activity relationship (QSAR) models were developed. Methods: The activities against MAC of 29 structurally heterogeneous drugs were examined by means of linear discriminant analysis (LDA) and multilinear regression analysis (MLRA) by using topological indices (TI) as structural descriptors. In vitro antimycobacterial activities were determined by a broth microdilution method with 7H9 medium. Results: The topological model obtained successfully classifies over 80% of compounds as active or inactive; consequently, it was applied in the search fo…

PharmacologyMicrobiology (medical)Virtual screeningQuantitative structure–activity relationshipbiologymedicine.drug_classBroth microdilutionQuantitative Structure-Activity RelationshipMicrobial Sensitivity TestsComputational biologyMycobacterium avium Complexbiology.organism_classificationLinear discriminant analysisAntimycobacterialModels BiologicalIn vitroAnti-Bacterial AgentsMicrobiologyInfectious DiseasesDrug DesignmedicinePharmacology (medical)Mycobacterium avium complexMolecular topologyJournal of Antimicrobial Chemotherapy
researchProduct

Rhabdomyolysis associated with the co-administration of daptomycin and pegylated interferon  -2b and ribavirin in a patient with hepatitis C

2011

PharmacologyMicrobiology (medical)business.industryRibavirinPegylated interferon αHepatitis CPharmacologymedicine.diseasechemistry.chemical_compoundInfectious DiseaseschemistryMedicinePharmacology (medical)DaptomycinbusinessRhabdomyolysisCo administrationmedicine.drugJournal of Antimicrobial Chemotherapy
researchProduct

Development and Partial Characterization of a Human T-Lymphoblastic Leukemic (CCRF-CEM) Cell Line Resistant to Etoposide. Analysis of Possible Circum…

1996

We have selected an etoposide-resistant variant (CCRF-CEM/VP-16) of the human T-lymphoblastic CCRF-CEM leukemia for study. Resistance to the topoisomerase II (topo II) inhibitor was about 11-fold and stable. Other data revealed that the new cell line had acquired an atypical, non-P-glycoprotein overexpressing multidrug resistant (MDR) phenotype with cross-resistance to other topo II inhibitors (amsacrine, doxorubicin, and mitoxantrone) and to glucocorticoids, but not to novobiocin, ICRF-187, vincristine or cisplatin. In a first instance, we assumed that altered drug-topo II interactions, based on quantitative and/or qualitative modifications of the enzyme, are a cause of resistance in the c…

PharmacologyMitoxantroneVincristineLeukemia T-CellDrug resistanceBiologymedicine.diseaseAntineoplastic Agents PhytogenicDrug Resistance MultipleMultiple drug resistanceLeukemiaInfectious DiseasesOncologyDrug Resistance NeoplasmCyclosporin aImmunologyTumor Cells CulturedmedicineCancer researchHumansPharmacology (medical)AmsacrineEtoposideEtoposidemedicine.drugJournal of Chemotherapy
researchProduct

2015

ABSTRACT Dengue fever is a severe, widespread, and neglected disease with more than 2 million diagnosed infections per year. The dengue virus NS2B/NS3 protease (PR) represents a prime target for rational drug design. At the moment, there are no clinical PR inhibitors (PIs) available. We have identified diaryl (thio)ethers as candidates for a novel class of PIs. Here, we report the selective and noncompetitive inhibition of the serotype 2 and 3 dengue virus PR in vitro and in cells by benzothiazole derivatives exhibiting 50% inhibitory concentrations (IC 50 s) in the low-micromolar range. Inhibition of replication of DENV serotypes 1 to 3 was specific, since all substances influenced neither…

PharmacologyNS3ProteasevirusesHepatitis C virusmedicine.medical_treatmentIn vitro toxicologyDengue virusBiologymedicine.disease_causemedicine.diseaseVirologyIn vitroDengue feverInfectious DiseasesViral replicationmedicinePharmacology (medical)Antimicrobial Agents and Chemotherapy
researchProduct

Adverse Reactions to Anti-SARS-CoV-2 Vaccine: A Prospective Cohort Study Based on an Active Surveillance System

2022

To date, Coronavirus disease (COVID-19) has caused high morbidity and mortality worldwide. To counteract the pandemic scenario, several vaccines against the etiological factor of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) were developed and tested. At the end of December 2020, BNT162b2 (Comirnaty, Pfizer-BioNTech) was the first and only authorized vaccine in Italy for selected categories, such as healthcare workers, fragile patients and people aged over 80 years old. To master our knowledge about BNT162b2 adverse reactions (ARs), an active surveillance system based on instant messaging was realized for voluntary participants who had been vaccinated at COVID-19 Vaccination …

PharmacologySARS-CoV-2Immunologyadverse reactionactive surveillance systemadverse reaction; vaccine; coronavirus; SARS-CoV-2; m-RNA; female; young people; active surveillance systemyoung peoplecoronavirufemaleInfectious DiseasesvaccineDrug DiscoveryPharmacology (medical)m-RNAVaccines
researchProduct

Multidimensional Frailty and Vaccinations in Older People: A Cross-Sectional Study

2022

It is known that influenza, herpes zoster, pneumococcal and pertussis infections may increase morbidity and mortality in older people. Vaccinations against these pathogens are effective in older adults. Frailty seems to be an important determinant of vaccination rates, yet data supporting this association are still missing. Therefore, we aimed to investigate the prevalence of four recommended vaccinations (influenza, herpes zoster, pneumococcal and diphtheria-tetanus-pertussis) and the association with multidimensional frailty assessed using a self-reported comprehensive geriatric assessment tool, i.e., the multidimensional prognostic index (SELFY-MPI). Older participants visiting the outpa…

PharmacologySettore MED/07 - Microbiologia E Microbiologia ClinicaSettore MED/09 - Medicina InternapneumococcuImmunologydiphtheria-tetanus-pertussisherpes zostermultidimensional prognostic index; vaccination; influenza; herpes zoster; pneumococcus; diphtheria-tetanus-pertussisvaccinationSettore MED/42 - Igiene Generale E Applicatamultidimensional prognostic indexdiphtheria-tetanus-pertussivaccination.Infectious DiseasesDrug DiscoveryPharmacology (medical)diphtheria-tetanus-pertussis; herpes zoster; influenza; multidimensional prognostic index; pneumococcus; vaccinationinfluenzapneumococcusVaccines; Volume 10; Issue 4; Pages: 555
researchProduct

Age and Cytokine Gene Variants Modulate the Immunogenicity and Protective Effect of SARS-CoV-2 mRNA-Based Vaccination

2023

The introduction of anti-SARS-CoV-2 vaccines in late 2020 substantially changed the pandemic picture, inducing effective protection in the population. However, individual variability was observed with different levels of cellular response and neutralizing antibodies. We report data on the impact of age, gender, and 16 single nucleotide polymorphisms (SNPs) of cytokine genes on the anti-SARS-CoV-2 IgG titers measured 31 and 105 days after administration of the second dose of BNT162b2 vaccine to 122 healthy subjects from the health care staff of the Palermo University Hospital, Italy. The higher titers at 31 days were measured in the younger subjects and in subjects bearing T-positive genotyp…

PharmacologyTNFA rs1800629anti-SARS-CoV-2 S1/S2 IgGanti-SARS-CoV-2 vaccineSettore MED/07 - Microbiologia E Microbiologia ClinicaImmunologyanti-SARS-CoV-2 vaccine; anti-SARS-CoV-2 S1/S2 IgG; cytokine gene SNPs; <i>IL-1R1 rs2234650</i>; <i>IL-6 rs1800795</i>; <i>IL-4 rs2243250</i>; <i>TNFA rs1800629</i>IL-1R1 rs2234650Infectious DiseasesIL-4 rs2243250Drug DiscoveryIL-6 rs1800795Settore MED/05 - Patologia ClinicaPharmacology (medical)cytokine gene SNPs.
researchProduct